Literature DB >> 15325061

Emerging fungal diseases: the importance of the host.

Gary W Procop1, Glenn D Roberts.   

Abstract

More yeasts and molds are now recognized to cause more human disease than ever before. This development is not due to a change in the virulence of these fungi, but rather to changes in the human host. These changes include immunosuppression secondary to the pandemic of HIV, the use of life-saving advances in chemotherapy and organ transplantation, and the use of corticosteroids and other immunosuppressive agents to treat a variety of diseases. Fungi that were once considered common saprophytes are now recognized as potential pathogens in these patients. This situation necessitates better communication than ever between the clinician, pathologist, and clinical mycologist to ensure the prompt and accurate determination of the cause of fungal diseases.

Entities:  

Mesh:

Year:  2004        PMID: 15325061     DOI: 10.1016/j.cll.2004.05.004

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  8 in total

1.  Evaluation of molecular diagnostic assays for fungal infections.

Authors:  Gary W Procop
Journal:  J Mol Diagn       Date:  2006-07       Impact factor: 5.568

2.  Mucosal Candida infection and colonisation as well as associated risk factors in solid organ transplant recipients.

Authors:  L Antoniewicz; D Relijc; C Poitschek; E Presterl; A Geusau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-04-02       Impact factor: 3.267

3.  Molecular diagnostics for invasive fungal infections: a call for refinement and implementation.

Authors:  Gary W Procop
Journal:  J Mol Diagn       Date:  2009-12-10       Impact factor: 5.568

4.  A review of patents (2011-2015) towards combating resistance to and toxicity of aminoglycosides.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2015-11-19       Impact factor: 3.597

5.  Fungal infection in a patient with multiple sclerosis.

Authors:  D Pisa; R Alonso; L Carrasco
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-01       Impact factor: 3.267

6.  Characterization of a new clinical yeast species, Candida tunisiensis sp. nov., isolated from a strain collection from Tunisian hospitals.

Authors:  Jamel Eddouzi; Valérie Hofstetter; Marizeth Groenewald; Mohamed Manai; Dominique Sanglard
Journal:  J Clin Microbiol       Date:  2012-10-17       Impact factor: 5.948

7.  Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients.

Authors:  Marisa H Miceli; Pranatharthi Chandrasekar
Journal:  Infect Drug Resist       Date:  2012-01-11       Impact factor: 4.003

8.  Protective Efficacy of Lectin-Fc(IgG) Fusion Proteins In Vitro and in a Pulmonary Aspergillosis In Vivo Model.

Authors:  Claudia Rodriguez-de la Noval; Susana Ruiz Mendoza; Diego de Souza Gonçalves; Marina da Silva Ferreira; Leandro Honorato; José Mauro Peralta; Leonardo Nimrichter; Allan J Guimarães
Journal:  J Fungi (Basel)       Date:  2020-10-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.